The Leadership Team at reMYND is responsible for setting the strategic vision and direction of the company, guiding research and development efforts in disease-modifying treatments for protein misfolding disorders. Comprising experts in scientific and business domains, the team collaborates to drive innovation, oversee operational excellence, and foster partnerships to advance therapeutic solutions and improve patient outcomes.
View all